Neurofibromatosis News and Research

RSS
Neurofibromatosis is a genetic condition in which tumors form on the nerves of the inner ear and cause loss of hearing and balance. Tumors may also occur in the brain and on nerves in the skull and spinal cord, and may cause loss of speech, eye movement, and the ability to swallow. Also called acoustic neurofibromatosis and NF2.
Targeting immune cells could potentially treat some kinds of brain tumor, study suggests

Targeting immune cells could potentially treat some kinds of brain tumor, study suggests

Children's Tumor Foundation establishes significant research initiative to combat NF2

Children's Tumor Foundation establishes significant research initiative to combat NF2

Study discovers origin of neurofibromas that develop throughout the skin of NF1 patients

Study discovers origin of neurofibromas that develop throughout the skin of NF1 patients

Research into cancer signaling network reveals new roadmap to tumor control

Research into cancer signaling network reveals new roadmap to tumor control

Royal Holloway professors to lead new to research into curing Neurofibromatosis type 1

Royal Holloway professors to lead new to research into curing Neurofibromatosis type 1

Mice sleeping fitfully help unravel mystery of insomnia

Mice sleeping fitfully help unravel mystery of insomnia

Scientists move one step closer towards treatment for low-grade gliomas with SYNODOS

Scientists move one step closer towards treatment for low-grade gliomas with SYNODOS

CTF along with NTAP and Sage announce first-ever open data portal for neurofibromatosis

CTF along with NTAP and Sage announce first-ever open data portal for neurofibromatosis

Slow-growing type of glioma may be vulnerable to immunotherapy, suggests study

Slow-growing type of glioma may be vulnerable to immunotherapy, suggests study

Research shows enlarged genotype-phenotype correlation for three-base pair deletion in NF1

Research shows enlarged genotype-phenotype correlation for three-base pair deletion in NF1

BeiGene collaborates with SpringWorks to evaluate new combinational therapy for solid tumors

BeiGene collaborates with SpringWorks to evaluate new combinational therapy for solid tumors

Researchers find how NF2 gene mutations lead to out-of-control cellular proliferation

Researchers find how NF2 gene mutations lead to out-of-control cellular proliferation

RDMD raises $3 million in seed funding to accelerate rare disease research, drug development

RDMD raises $3 million in seed funding to accelerate rare disease research, drug development

EMA grants orphan designation to selumetinib for treatment of neurofibromatosis type 1

EMA grants orphan designation to selumetinib for treatment of neurofibromatosis type 1

Auditory brainstem implant helps patients with neurofibromatosis type 2

Auditory brainstem implant helps patients with neurofibromatosis type 2

Researchers show how Spred1 molecule protects HSC homeostasis under diet-induced stress

Researchers show how Spred1 molecule protects HSC homeostasis under diet-induced stress

FDA-approved drug for chemical abortion shows promise for treatment of vestibular schwannoma

FDA-approved drug for chemical abortion shows promise for treatment of vestibular schwannoma

Plymouth researcher receives grant to further investigate causes of hereditary neuro-tumors

Plymouth researcher receives grant to further investigate causes of hereditary neuro-tumors

Scientists suggest new strategy to inhibit untreatable, deadly nerve sheath tumors

Scientists suggest new strategy to inhibit untreatable, deadly nerve sheath tumors

Exploring the Future of Breast Cancer Risk Assessment

Exploring the Future of Breast Cancer Risk Assessment